skip to Main Content

Neurodegenerative diseases are among the most pressing and devastating health challenges facing aging populations globally.

  • Our group aims to develop therapies to prevent, slow or reverse neurodegenerative disease, and to match these therapies with individual patients.
  • We combine molecular- and cellular-level understanding of protein-misfolding, a central pathological process in neurodegeneration,  with genomics,  stem cell technologies and innovative clinical trial design.



Back To Top